Gallantt Ispat Ltd.
GALLANTTGallantt Ispat Ltd. is printing record margins on a fuller multiple. From here the earnings must do all the lifting.
The sharpest disagreement: annual EPS moved +20.8% against a −18.8% price move — the market has not yet caught up with the delivery.
The price is in a confirmed uptrend (158 weeks in) while the P/E sits at the 94th percentile of its own 10-year range. Underneath, the last four quarters read deteriorating — profit −28.7% year on year, and 137% of the last 3 years' profit arrived as cash. What settles it: whether the price catches up with earnings that have already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Gallantt Ispat Ltd. trades at ₹615, in a confirmed uptrend and 158 weeks into that stage. That is −2.4% against its own 200-day average. It sits at 28% of a 52-week range of ₹517 to ₹869. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (8 weeks and counting).
Today the stock is in a confirmed uptrend — week 158 of stage 2, confirmed. At ₹615 it trades −2.4% versus its 200-day average and sits at 28% of its 52-week range (₹517–₹869).
Against the market, two honest reads. Cumulative: over the last 10.4 years the stock moved +2,056% while the NIFTY 500 moved +276% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (8 weeks and counting; last ahead the week of 2026-06-19) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Gallantt Ispat Ltd. trades at 34.0× P/E, at the pricey end of its own range (94th percentile). Its long-run median P/E is 8.1×, measured across 9.9 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 34.0× is at the pricey end of its own range (94th percentile), against a long-run median of 8.1× measured over 9.9 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved +20.8% against a −18.8% price move — earnings outran the price, pushing the multiple DOWN its own range.
The price move, decomposed: over 5y, of the +49.2%/yr price move, ~+12.5%/yr came from earnings growth and ~+36.7 pp from the multiple (expanding); over 10y, of the +31.8%/yr price move, ~+12.4%/yr came from earnings growth and ~+19.4 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: Topping out Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Gallantt Ispat Ltd. reads as topping out on its fundamental arc. Topping out — profit and EPS growth have decelerated hard (profit growth +91.9% at its peak → −3.8% latest) while ROCE still reads 19.2%. The read is built from 12 quarters across 4 curves, on full evidence.
Why it matters: decelerating from a peak is where good stories quietly end — the multiple usually notices late.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +2.9% | +2.9% | +34.4% | +20.8% |
| Profit | +20.7% | +50.8% | +43.0% | +26.5% |
| EPS | +20.8% | +50.9% | +14.9% | +13.6% |
| Share price | −18.8% | +91.0% | +49.2% | +31.8% |
4-Factor Sector Score
34.9/100 — rank 11 of 17 in Steel Products · 100% evidence confidence
Gallantt Ispat Ltd. scores 34.9 out of 100 against the 17 companies it is compared with in Steel Products, ranking 11. Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression.
The four contributions add to the total exactly: 8.8 + 16.7 + 6.9 + 2.5 = 34.9. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Gallantt Ispat Ltd. reported ₹1,146 Cr of revenue in the Jun 26 quarter, +1.6% year on year. That is the 2nd straight quarter of year-on-year growth. Over 10 years it has compounded at 20.8% a year. The last full year, FY26, came in at ₹4,419 Cr. The last four reported quarters add to ₹4,438 Cr.
FY26 revenue came in at ₹4,419 Cr (+2.9% on the year), capping 10 years at 20.8% compound. The latest quarter (Jun 26) printed ₹1,146 Cr, +1.6% year on year — the 2nd consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +4.4% growth against the decade's 20.8% — the current year is running slower than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +4.2% over the last 4 quarters against +1.0%/yr over the last 8 — accelerating; TTM profit −3.8% vs +17.5%/yr — rolling over.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Gallantt Ispat Ltd.'s operating margin is 16.0% in the Jun 26 quarter, −6.0 percentage points against the same quarter a year ago. That is the widest this company has ever printed on a full-year basis. Across 12 fiscal years the operating margin has ranged 3.7% to 16.0%. The current quarter sits inside that band.
The latest quarter's operating margin is 16.0%, −6.0 pp against the same quarter a year ago. Across 12 fiscal years the operating margin has ranged 3.7%–16.0%, and FY26's 16.0% is the top of that band — a record year.
🚨 Why the margin moved: operating margin went −5.7 pp year on year while gross margin went −4.2 pp — the loss came mostly from the gross line: input costs and pricing.
Worth repeating from the valuation section: cheap against its own history on record margins is not the same thing as cheap — a record margin flatters every ratio built on top of it.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Gallantt Ispat Ltd. earned ₹124 Cr of net profit in the Jun 26 quarter, −28.7% year on year. Full-year FY26 profit was ₹484 Cr. The 10-year compound rate is 26.5%. That is 10.8% of the quarter's revenue. The same quarter a year earlier earned ₹174 Cr.
Jun 26 profit was ₹124 Cr, −28.7% year on year. On the full year, FY26 printed ₹484 Cr (+20.7%), and the 10-year compound rate is 26.5%.
🚨 Why profit moved: revenue contributed +1.6% and the margin −6.0 pp — the quarter was revenue-led despite a thinner margin.
Pace comparison, last four quarters: profit +11.6% vs revenue +4.4%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 137% of Gallantt Ispat Ltd.'s reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹602 Cr of operating cash against ₹484 Cr of profit. After ₹210 Cr of capital spending, ₹392 Cr was left as free cash.
FY26: operating cash of ₹602 Cr against reported profit of ₹484 Cr, leaving free cash of ₹392 Cr after ₹210 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 137% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why conversion sits at 137%: the cash cycle held roughly steady between FY21 and FY26 — so conversion tracks profitability rather than the cycle.
Router verdict: the bigger cash user is investment — capital spending ran 1.7× depreciation over three years, so the next section's job is to check what that build-out is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Gallantt Ispat Ltd.'s cash conversion cycle runs 58 days in FY26, down from 66 days in FY21. Capital spending ran ₹632 Cr over the last 3 years. At FY26 sales of ₹4,419 Cr each day of that cycle holds about ₹12.1 Cr, so roughly ₹702 Cr sits inside the business at any moment.
FY26: debtors at 15 days, inventory at 63 days — roughly 2.1 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 58 days, tighter than FY21's 66.
The full loop: cash goes out to suppliers and production on day 0; stock waits 63 days to sell; customers pay about 15 days after that; and suppliers themselves are paid at 20 days — netting out to the 58-day cycle.
In money terms: at FY26 sales of ₹4,419 Cr, each day of the cycle holds about ₹12.1 Cr — so the 58-day loop keeps roughly ₹702 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹632 Cr over the last 3 fiscal years against ₹366 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹349 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
Gallantt Ispat Ltd. earns a ROCE of 18% in FY26. That is up from a trough of 3% in FY20. Return on invested capital clears the cost of that capital by +0.4 percentage points, so growth here adds value rather than only size. The wiring behind it is 11.0% net margin on 1.03× asset turns.
FY26 ROCE is 18%, recovered from a FY20 trough of 3% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY26): 11.0% net margin × 1.03× asset turns × 1.29× balance-sheet leverage ≈ 14.6% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.
The capstone test — ROIC − WACC: 12.4% − 12.0% = a +0.4 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Positive but thin — value creation with little room for error.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
Gallantt Ispat Ltd. carries total debt of ₹548 Cr against shareholder equity of ₹3,316 Cr as of Mar 26, a debt-to-equity of 0.17 — effectively unlevered. On the annual view that ratio went from 0.19 in FY22 to 0.17 in FY26. The returns elsewhere on this page are therefore earned rather than borrowed.
Mar 26: total debt of ₹548 Cr against shareholder equity of ₹3,316 Cr — a debt-to-equity of 0.17. On the annual view, debt-to-equity went from 0.19 (FY22) to 0.17 (FY26). The returns on this page are earned, not borrowed.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Promoters added 1.1 points of Gallantt Ispat Ltd. over 8 quarters, the biggest move on the register. That takes promoters to 70.0% of the company. Foreign institutions moved −0.1 points over the same window, to 0.0%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Promoters: +1.1 points over 8 quarters to 70.0%; Foreign institutions: −0.1 points over 8 quarters to 0.0%; Domestic institutions: +0.1 points over 8 quarters to 0.1%.
Why the register moved: promoters drove it (+1.1 points) — steady accumulation by institutions reading the same numbers this page reads.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Gallantt Ispat Ltd.: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Shyam Metalics & Energy LtdSHYAMMETL | 69.2/100Favorable setup97% evidence | LEADER | 26.3/35 Revenue 22.8% · PAT 21.3% · OPM change 1 pp 95% evidence | 13.8/25 ROCE 13% · OPM 14% 95% evidence | 12.3/20 P/E 25.6× · PEG 1.19 100% evidence | 16.8/20 RS sector 3.4% · RS bench 14.5% · 1Y 6.4%11 of 12 weeks ahead 100% evidence |
| Exact sum: 26.3 + 13.8 + 12.3 + 16.8 = 69.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2Raghav Productivity Enhancers LtdRPEL | 68.6/100Favorable setup94% evidence | TURNING | 31.8/35 Revenue 34.3% · PAT 53.7% · OPM change 3 pp 100% evidence | 19.5/25 ROCE 30.3% · OPM 30% 100% evidence | 5.2/20 P/E 89.1× · PEG 2.31 100% evidence | 12.1/20 RS sector -2.6% · RS bench 41.8% · 1Y 83.6%11 of 11 weeks ahead 70% evidence |
| Exact sum: 31.8 + 19.5 + 5.2 + 12.1 = 68.6 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 3Kamdhenu LtdKAMDHENU | 67.0/100Favorable setup66% evidence | LEADER | 19.9/35 Revenue 34.5% · PAT 74.7% · OPM change -2 pp 35% evidence | 16.3/25 ROCE 16.9% · OPM 7.2% 95% evidence | 11.0/20 P/E 31.8× · PEG — 50% evidence | 19.8/20 RS sector 18.2% · RS bench 30.6% · 1Y 14.9%11 of 12 weeks ahead 100% evidence |
| Exact sum: 19.9 + 16.3 + 11 + 19.8 = 67 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Sunflag Iron & Steel Company LtdSUNFLAG | 64.0/100Mixed-positive evidence96% evidence | LEADER | 23.4/35 Revenue 11.4% · PAT 25.3% · OPM change 1 pp 88% evidence | 10.3/25 ROCE 4.1% · OPM 12% 100% evidence | 11.5/20 P/E 31.6× · PEG 0.65 100% evidence | 18.8/20 RS sector 15.5% · RS bench 27% · 1Y 28.5%12 of 12 weeks ahead 100% evidence |
| Exact sum: 23.4 + 10.3 + 11.5 + 18.8 = 64 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5BMW Industries Ltd542669 | 60.8/100Mixed-positive evidence78% evidence | BREAKING OUT | 20.8/35 Revenue 5.9% · PAT 8% · OPM change 7 pp 83% evidence | 15.1/25 ROCE 12.4% · OPM 28% 76% evidence | 13.3/20 P/E 13.3× · PEG — 50% evidence | 11.6/20 RS sector -2.8% · RS bench 6.7% · 1Y -7%12 of 12 weeks ahead 100% evidence |
| Exact sum: 20.8 + 15.1 + 13.3 + 11.6 = 60.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Vardhman Special Steels LtdVSSL | 57.7/100Mixed-positive evidence93% evidence | LEADER | 15.7/35 Revenue 6.3% · PAT 1.1% · OPM change 4.8 pp 100% evidence | 14.1/25 ROCE 16.5% · OPM 11.8% 100% evidence | 15.0/20 P/E 32× · PEG 0.42 65% evidence | 12.9/20 RS sector 0.2% · RS bench 11.1% · 1Y 18.1%11 of 12 weeks ahead 100% evidence |
| Exact sum: 15.7 + 14.1 + 15 + 12.9 = 57.7 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 7Rhetan TMT LtdRHETAN | 53.0/100Mixed-positive evidence89% evidence | FADING | 23.1/35 Revenue -34.3% · PAT 100% · OPM change 76.5 pp 88% evidence | 12.4/25 ROCE 10.9% · OPM 29.9% 100% evidence | 3.7/20 P/E 237× · PEG 3.94 65% evidence | 13.8/20 RS sector 9.8% · RS bench 21.6% · 1Y 80.2%8 of 12 weeks ahead 100% evidence |
| Exact sum: 23.1 + 12.4 + 3.7 + 13.8 = 53 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8Kalyani Steels LtdKSL | 52.3/100Mixed-positive evidence96% evidence | FADING | 12.4/35 Revenue -6.9% · PAT 1.6% · OPM change -1 pp 88% evidence | 17.4/25 ROCE 14.8% · OPM 20% 100% evidence | 12.2/20 P/E 14.5× · PEG 1.01 100% evidence | 10.3/20 RS sector -1.2% · RS bench 9.4% · 1Y -2.2%11 of 12 weeks ahead 100% evidence |
| Exact sum: 12.4 + 17.4 + 12.2 + 10.3 = 52.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9Steel Exchange India LtdSTEELXIND | 44.5/100Mixed-negative evidence80% evidence | LEADER | 11.8/35 Revenue -12.8% · PAT -8.8% · OPM change 3 pp 95% evidence | 9.4/25 ROCE 10.9% · OPM 13% 95% evidence | 9.4/20 P/E 45.1× · PEG — 15% evidence | 13.9/20 RS sector 3.2% · RS bench 13.6% · 1Y 5.9%12 of 12 weeks ahead 100% evidence |
| Exact sum: 11.8 + 9.4 + 9.4 + 13.9 = 44.5 · Decision use: Price leads the evidence: RS versus the benchmark is 13.6%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 10Prakash Industries LtdPRAKASH | 44.3/100Mixed-negative evidence77% evidence | ASLEEP | 12.1/35 Revenue -13.3% · PAT -6.2% · OPM change 0 pp 83% evidence | 12.1/25 ROCE 9.6% · OPM 16% 95% evidence | 14.1/20 P/E 6.6× · PEG — 50% evidence | 6.0/20 RS sector -9.1% · RS bench -14.5% · 1Y -30.1%7 of 10 weeks ahead 70% evidence |
| Exact sum: 12.1 + 12.1 + 14.1 + 6 = 44.3 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 11Gallantt Ispat Ltd.this pageGALLANTT | 34.9/100Adverse evidence100% evidence | ASLEEP | 8.8/35 Revenue 4.2% · PAT -3.8% · OPM change -6 pp 100% evidence | 16.7/25 ROCE 18.2% · OPM 16% 100% evidence | 6.9/20 P/E 34× · PEG 1.7 100% evidence | 2.5/20 RS sector -12.9% · RS bench -3.7% · 1Y -3.2%8 of 12 weeks ahead 100% evidence |
| Exact sum: 8.8 + 16.7 + 6.9 + 2.5 = 34.9 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression. | ||||||
| 12Salasar Techno Engineering LtdSALASAR | 33.7/100Adverse evidence69% evidence | ASLEEP | 13.3/35 Revenue 4.9% · PAT -33.3% · OPM change -2.9 pp 62% evidence | 8.2/25 ROCE 8.1% · OPM 3.1% 95% evidence | 8.3/20 P/E 59.3× · PEG — 50% evidence | 3.9/20 RS sector -16.5% · RS bench -27.2% · 1Y -19.7%0 of 10 weeks ahead 70% evidence |
| Exact sum: 13.3 + 8.2 + 8.3 + 3.9 = 33.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 13Panchmahal Steel LtdPANCHMSTEL | 33.3/100Adverse evidence61% evidence | ASLEEP | 15.2/35 Revenue 0.3% · PAT -80% · OPM change 3.5 pp 62% evidence | 4.3/25 ROCE 3.1% · OPM 3.5% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 3.8/20 RS sector -11.7% · RS bench -1.6% · 1Y 18.3%0 of 12 weeks ahead 100% evidence |
| Exact sum: 15.2 + 4.3 + 10 + 3.8 = 33.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14Jindal Steel LtdJINDALSTEL | 33.0/100Adverse evidence100% evidence | ASLEEP | 12.3/35 Revenue 16.5% · PAT -9.8% · OPM change -7 pp 100% evidence | 9.7/25 ROCE 9.7% · OPM 17% 100% evidence | 6.1/20 P/E 36.4× · PEG 2.69 100% evidence | 4.9/20 RS sector -11.2% · RS bench -1.2% · 1Y 10.2%1 of 12 weeks ahead 100% evidence |
| Exact sum: 12.3 + 9.7 + 6.1 + 4.9 = 33 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15Beekay Steel Industries LtdBEEKAY | 30.2/100Adverse evidence77% evidence | ASLEEP | 9.6/35 Revenue 9.3% · PAT -58.9% · OPM change -2 pp 83% evidence | 7.7/25 ROCE 5.5% · OPM 7% 95% evidence | 8.2/20 P/E 20.4× · PEG — 50% evidence | 4.7/20 RS sector -13.7% · RS bench -7.2% · 1Y -19.4%1 of 6 weeks ahead 70% evidence |
| Exact sum: 9.6 + 7.7 + 8.2 + 4.7 = 30.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16Electrotherm (India) LtdELECTHERM | 24.3/100Adverse evidence67% evidence | TURNING | 5.1/35 Revenue -10.3% · PAT -80% · OPM change -3.9 pp 83% evidence | 2.1/25 ROCE 0.5% · OPM 2.1% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 7.1/20 RS sector -28.1% · RS bench 13.4% · 1Y -1.5%9 of 10 weeks ahead 70% evidence |
| Exact sum: 5.1 + 2.1 + 10 + 7.1 = 24.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 17Banganga Paper Industries LtdBANGANGA | 45.4/100Thin evidence · provisional45% evidence | 19.7/35 Revenue 100% · PAT 100% · OPM change -2 pp 40% evidence | 14.2/25 ROCE 27% · OPM 5.7% 57% evidence | 8.5/20 P/E 347× · PEG — 15% evidence | 3.0/20 RS sector -30.2% · RS bench -32.7% · 1Y -46.5%8 of 12 weeks ahead to 2026-03-08 70% evidence | |
| Exact sum: 19.7 + 14.2 + 8.5 + 3 = 45.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Gallantt Ispat Ltd.'s share price today?
Gallantt Ispat Ltd. trades at ₹615, −18.8% over the past year. The company is valued at ₹14,829 Cr. The stock sits at 28% of its 52-week range of ₹517–₹869, −2.4% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 158 weeks in. — as of 31 July 2026.
What were Gallantt Ispat Ltd.'s latest quarterly results?
Gallantt Ispat Ltd. reported revenue of ₹1,146 Cr and net profit of ₹124 Cr for the Jun 26 quarter. Revenue rose 1.6% and profit fell 28.7% year on year. Earnings per share were ₹5.13. The operating margin was 16.0%, 6.0 pp lower than a year earlier. — as of 31 July 2026.
What is Gallantt Ispat Ltd.'s revenue?
Gallantt Ispat Ltd. reported revenue of ₹1,146 Cr in the Jun 26 quarter, +1.6% year on year. For the full FY26 fiscal year, revenue was ₹4,419 Cr (+2.9%). Over the last 10 years revenue compounded at 20.8% a year. — as of 31 July 2026.
What is Gallantt Ispat Ltd.'s profit?
Gallantt Ispat Ltd. earned ₹124 Cr of net profit in the Jun 26 quarter, −28.7% year on year. Full-year FY26 profit was ₹484 Cr. The operating margin ran 16.0% in the latest quarter. — as of 31 July 2026.
What is Gallantt Ispat Ltd.'s market cap?
Gallantt Ispat Ltd.'s market capitalisation is ₹14,829 Cr at a share price of ₹615. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 31 July 2026.
What is Gallantt Ispat Ltd.'s P/E ratio?
Gallantt Ispat Ltd. trades at a P/E of 34.0×, at the 94th percentile of its own 10-year range, against a long-run median of 8.1×. This is a comparison with the stock's own history, not a value call — as of 31 July 2026.
Does Gallantt Ispat Ltd. pay a dividend?
Yes — Gallantt Ispat Ltd.'s dividend payout was 10% of profit in FY26, and it recorded a payout in 5 of its last 12 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 31 July 2026.
Is Gallantt Ispat Ltd. overvalued?
On its own history, Gallantt Ispat Ltd. looks expensive against its own history: its P/E of 34.0× sits at the 94th percentile of its 10-year range (long-run median 8.1×). That is a percentile read against the stock's own past, not a price opinion or a direction call. One caveat: margins are the best this company has ever printed — cheap on record margins is not the same thing as cheap. — as of 31 July 2026.
Is Gallantt Ispat Ltd. growing?
Not right now — Gallantt Ispat Ltd.'s latest numbers are shrinking: latest-quarter revenue +1.6% year on year, profit −28.7%, and the margin −6.0 pp at 16.0%. The 10-year compound rates are 20.8% (revenue) and 26.5% (profit). The earnings engine currently reads: deteriorating — as of 31 July 2026.
How is Gallantt Ispat Ltd. performing?
Gallantt Ispat Ltd. is in a confirmed uptrend, 158 weeks in. Its latest quarter's revenue rose 1.6% and profit fell 28.7% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 8 weeks. This describes what the data did, not a rating. — as of 31 July 2026.
What stage is Gallantt Ispat Ltd. in?
Topping out — profit and EPS growth have decelerated hard (profit growth +91.9% at its peak → −3.8% latest) while ROCE still reads 19.2%. The read comes from the last 12 quarters of growth (revenue growth +4.2% latest, profit growth −3.8% latest, eps growth −3.7% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 31 July 2026.
Is Gallantt Ispat Ltd. in an uptrend?
Yes — the price is in a confirmed uptrend (week 158 of stage 2), trading −2.4% versus its 200-day average and at 28% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 31 July 2026.
Is Gallantt Ispat Ltd. beating the market?
Not lately — on a trailing-13-week view Gallantt Ispat Ltd. is currently behind the NIFTY 500 (8 weeks and counting; last ahead the week of 2026-06-19), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.4 years the stock moved +2,056% against the NIFTY 500's +276% — ahead of the index over the full window. — as of 31 July 2026.
Will Gallantt Ispat Ltd.'s share price go up?
This page publishes no price forecast for Gallantt Ispat Ltd. What it measures instead: the share price is ₹615, the price is in a confirmed uptrend 158 weeks in. Its P/E of 34.0× sits at the 94th percentile of its own 10-year range. — as of 31 July 2026.
Who owns Gallantt Ispat Ltd.?
Promoters hold 70.0% of Gallantt Ispat Ltd., foreign institutions 0.0%, domestic institutions 0.1% and the public 29.9% (latest quarter). The biggest move on the register over the last two years: Promoters added 1.1 points over 8 quarters. — as of 31 July 2026.
Does Gallantt Ispat Ltd. have too much debt?
No — Gallantt Ispat Ltd.'s debt-to-equity is 0.17, and operating profit covers the interest bill 17×. FY26 borrowings were ₹548 Cr against equity of ₹3,316 Cr. The returns on this page are earned, not borrowed — as of 31 July 2026.
What is Gallantt Ispat Ltd.'s capex?
Gallantt Ispat Ltd. spent ₹632 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹210 Cr, with ₹349 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 31 July 2026.
What is Gallantt Ispat Ltd.'s cash flow?
Gallantt Ispat Ltd. generated ₹602 Cr of operating cash flow in FY26 and ₹392 Cr of free cash flow after ₹210 Cr of capital spending. Reported profit that year was ₹484 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 31 July 2026.
Is Gallantt Ispat Ltd.'s profit real cash?
Yes — over the last 3 fiscal years, 137% of Gallantt Ispat Ltd.'s reported profit arrived as operating cash. In FY26, operating cash was ₹602 Cr against reported profit of ₹484 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 31 July 2026.
Where is Gallantt Ispat Ltd. in its business cycle?
Gallantt Ispat Ltd.'s FY26 operating margin was 16.0%, against a 12-year band of 3.7%–16.0%: the top of the band — a record year. Record profitability is late-cycle territory: every ratio flatters at the top, and the story leans on margins holding. The latest quarter ran 16.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 31 July 2026.
What could break the Gallantt Ispat Ltd. story?
The sharpest disagreement: annual EPS moved +20.8% against a −18.8% price move — the market has not yet caught up with the delivery. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 31 July 2026.
Is Gallantt Ispat Ltd. a stock worth studying right now?
This is not investment advice. The machine read: Gallantt Ispat Ltd. is printing record margins on a fuller multiple. From here the earnings must do all the lifting. The sharpest open question: whether the price catches up with earnings that have already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 31 July 2026.